Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Kura Oncology (KURA) has a market cap of $0.61 billion USD. According to our data, Kura Oncology is ranked No.5867 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $0.61 B |
-9.76%
|
| Dec 31, 2024 | $0.68 B |
-39.43%
|
| Dec 29, 2023 | $1.12 B |
15.87%
|
| Dec 30, 2022 | $0.97 B |
-11.36%
|
| Dec 31, 2021 | $1.09 B |
-57.13%
|
| Dec 31, 2020 | $2.54 B |
137.53%
|
| Dec 31, 2019 | $1.07 B |
-2.07%
|
| Dec 31, 2018 | $1.09 B |
-8.24%
|
| Dec 29, 2017 | $1.19 B |
159.32%
|
| Dec 30, 2016 | $0.46 B |
-29.76%
|
| Dec 31, 2015 | $0.65 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
 Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
USA
|
 Revolution Medicines
RVMD
|
$7.56 B |
0.000 M
|
USA
|
 Relay Therapeutics
RLAY
|
$0.82 B |
0.000 M
|
USA
|
 Zymeworks
ZYME
|
$1.01 B |
-0.000 M
|
Canada
|
 BeiGene
BGNE
|
$20.21 B |
-0.311 B
|
China
|
 Exelixis
EXEL
|
$9.39 B |
0.000 M
|
USA
|
 Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
 Array Technologies
ARRY
|
$0.97 B |
0.000 M
|
USA
|
 Agios Pharmaceuticals
AGIO
|
$1.94 B |
-0.000 M
|
USA
|
 Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
 Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
 G1 Therapeutics
GTHX
|
$0.38 B |
0.000 M
|
USA
|
| Market Cap | = | KURA Stock Price | * | KURA Shares Outstanding |
| = | $7.86 | * | 77.76 M | |
| = | $0.61 B |